Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Buy Iron Mountain Incorporated (IRM)

Page 1 of 2

In the 21st century investor’s toolkit, there are plenty of metrics market participants can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite fund managers can beat the broader indices by a solid margin (see just how much).

Iron Mountain Incorporated (NYSE:IRM)

Just as necessary, bullish insider trading sentiment is another way to analyze the financial markets. There are a variety of motivations for an upper level exec to drop shares of his or her company, but just one, very simple reason why they would buy. Many empirical studies have demonstrated the market-beating potential of this method if investors understand where to look (learn more here).

Keeping this in mind, let’s analyze the latest info surrounding Iron Mountain Incorporated (NYSE:IRM).

How are hedge funds trading Iron Mountain Incorporated (NYSE:IRM)?

Heading into Q3, a total of 29 of the hedge funds we track held long positions in this stock, a change of 21% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of notable hedge fund managers who were boosting their holdings substantially.

When using filings from the hedgies we track, Highfields Capital Management, managed by Jonathon Jacobson, holds the biggest position in Iron Mountain Incorporated (NYSE:IRM). Highfields Capital Management has a $248.5 million position in the stock, comprising 2.1% of its 13F portfolio. Coming in second is Renaissance Technologies, managed by Jim Simons, which held a $54.7 million position; 0.1% of its 13F portfolio is allocated to the stock. Remaining hedge funds that hold long positions include Jeffrey Altman’s Owl Creek Asset Management, John C. Walker’s Stonerise Capital Management and D. E. Shaw’s D E Shaw.

With a general bullishness amongst the titans, specific money managers have been driving this bullishness. Highfields Capital Management, managed by Jonathon Jacobson, assembled the biggest position in Iron Mountain Incorporated (NYSE:IRM). Highfields Capital Management had 248.5 million invested in the company at the end of the quarter. Jim Simons’s Renaissance Technologies also made a $54.7 million investment in the stock during the quarter. The other funds with brand new IRM positions are Jeffrey Altman’s Owl Creek Asset Management, John C. Walker’s Stonerise Capital Management, and D. E. Shaw’s D E Shaw.

How have insiders been trading Iron Mountain Incorporated (NYSE:IRM)?

Insider buying is particularly usable when the primary stock in question has experienced transactions within the past half-year. Over the latest 180-day time frame, Iron Mountain Incorporated (NYSE:IRM) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll check out the relationship between both of these indicators in other stocks similar to Iron Mountain Incorporated (NYSE:IRM). These stocks are Jack Henry & Associates, Inc. (NASDAQ:JKHY), Solera Holdings Inc (NYSE:SLH), Total System Services, Inc. (NYSE:TSS), NetSuite Inc (NYSE:N), and Amdocs Limited (NYSE:DOX). This group of stocks are the members of the business software & services industry and their market caps match IRM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!